NR 565 advanced pharmacology FNP EXAM A+ GRADE ASSURED COMPLETE SOLUTIONS AND VERIFIED ANSWERS

PHARMACOLOGY EXAM vc




Exam Solution vc




NR565 / NR 565 Midterm Exam (Latest UPDATED): Adv vc vc vc vc vc vc vc vc




anced Pharmacology Fundamentals Chamberlain 2026 vc vc vc vc vc




A+ GRADE ASSURED COMPLETE SOLUTIONS AND VERIF
vc vc vc vc vc vc




IED ANSWERS (6615C) vc vc




QUESTION 1 vc




benefits of full practice authority vc vc vc vc




ANSWER

Nurse practitioners have the autonomy to evaluate patients, diagnose, order and interpret tests, initiate
vc vc vc vc vc vc vc vc vc vc vc vc vc vc



and manage treatments and prescribe medications, including controlled substances without physician o
vc vc vc vc vc vc vc vc vc vc vc



versight



QUESTION 2 vc




Beer's Criteria vc




ANSWER

identifies drugs with a high likelihood of causing adverse effects in older adults. Accordingly, drugs on t
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



his list should generally be avoided in adults older than 65 years except when the benefits are significan
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



tly greater than the risks.
vc vc vc vc




QUESTION 3 vc




Pharmacodynamics
ANSWER

the study of the biochemical and physiologic effects of drugs on the body and the molecular mechanism
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



s by which those effects are produced
vc vc vc vc vc vc




QUESTION 4 vc

, Pharmacokinetics
ANSWER

the study of drug movement throughout the body
vc vc vc vc vc vc vc




QUESTION 5 vc




Pharmacogenomics
ANSWER

the study of how genes affect a person's response to drugs. The purpose of this is to combine the scienc
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



es of genomics and pharmacology to provide individualized, targeted, safe drug therapies to patients
vc vc vc vc vc vc vc vc vc vc vc vc vc




QUESTION 6 vc




cultural influences in prescribing vc vc vc




ANSWER

The greatest concern surrounding race-
vc vc vc vc



based therapy has to do with genetic variability. We know there is great diversity within and among rac
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



ial groups; therefore, a "one fits all" approach based on race is unwise. Still, we can use known associati
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



ons to guide choices. For example, differences in metabolism between people with East Asian and Europ
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



ean heritage are common. The provider can use this knowledge to guide initial dosing (with adjustment,
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc v



as indicated based on response) if genetic testing is not feasible or warranted
c vc vc vc vc vc vc vc vc vc vc vc vc




QUESTION 7 vc




Polypharmacy: Definition, challenges, and outcomes vc vc vc vc




ANSWER

treatment with multiple drugs greatly increases the risk for interactions. Some of these interactions are
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



negligible, but some can have life- vc vc vc vc vc



threatening consequences. It is of crucial importance to ask the patient about all current drugs, includin
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



g over-the-
vc



counter (OTC) medications and other herbal preparations. Many patients do not consider OTC or altern
vc vc vc vc vc vc vc vc vc vc vc vc vc vc



ative pharmaceuticals as "medications" and may not mention them unless you ask specifically.
vc vc vc vc vc vc vc vc vc vc vc vc




QUESTION 8 vc




State Prescription Drug vc vc




ANSWER

Clinicians should review the patient's history of controlled substance prescriptions using state prescripti
vc vc vc vc vc vc vc vc vc vc vc vc



on drug monitoring program (PDMP) data to determine whether the patient is receiving opioid dosages
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc



or dangerous combinations that put him or her at high risk for overdose. Clinicians should review PDM
vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc vc